Diana M. Brainard

Senior Vice President & Head, Virology Therapeutic Area at Gilead Sciences, Inc.

Diana M. Brainard

Diana M. Brainard

Senior Vice President & Head, Virology Therapeutic Area at Gilead Sciences, Inc.

Biography

Diana Brainard is on the board of AlloVir, Inc. In the past she occupied the position of Senior VP-HIV & Emerging Viral Infections at Gilead Sciences, Inc. She received an undergraduate degree from Brown University and a doctorate from Tulane University School of Medicine.

Overview
Career Highlights

AlloVir, Inc.

RelSci Relationships

538

Number of Boards

1

Birthday

1971

Age

50

Relationships
RelSci Relationships are individuals Diana M. Brainard likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Vice President & Chief Financial Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Executive Vice President, Corporate Affairs & General Counsel at Gilead Sciences, Inc.

Relationship likelihood: Strong

Co-Founder at AlloVir, Inc.

Relationship likelihood: Strong

Co-Founder at AlloVir, Inc.

Relationship likelihood: Strong

Founding Director, Center for Cell & Gene Therapy at Baylor College of Medicine

Relationship likelihood: Strong

Executive Partner at MPM Capital, Inc.

Relationship likelihood: Strong

Director & Chief Development Officer at Marker Therapeutics, Inc.

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Chief Executive Officer, Kite at Gilead Sciences, Inc.

Relationship likelihood: Strong

Chief Financial Officer at Kite Pharma, Inc.

Relationship likelihood: Strong

Paths to Diana M. Brainard
Potential Connections via
Relationship Science
You
Diana M. Brainard
Senior Vice President & Head, Virology Therapeutic Area at Gilead Sciences, Inc.
Education

Brown University is located in historic Providence, Rhode Island and was founded in 1764. It is the seventh-oldest college in the United States. Brown is an independent, coeducational Ivy League institution comprising undergraduate and graduate programs, plus the Alpert Medical School, School of Public Health, School of Engineering, and the School of Professional Studies.

The Tulane University School of Medicine is located in New Orleans, Louisiana, USA and is a part of Tulane University. The school is located in the Medical District of the New Orleans Central Business District. The school was founded in 1834 as the Medical College of Louisiana and is the 15th oldest medical school in the United States and the 2nd oldest in the deep south. The first classes were held in 1835 at a variety of locations, including Charity Hospital and the Strangers Unitarian Church.

Career History
Chief Executive Officer
Effective 05/2021

AlloVir (formerly ViraCyte), founded in 2013 by researchers at Baylor College of Medicine’s Center for Cell and Gene Therapy, is the leader in the development of novel cell therapies with a focus on restoring natural T-cell immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The company’s technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. AlloVir’s technology and manufacturing process enables the potential for the treatment and/or prevention of up to six devastating viruses with its lead allogeneic product, Viralym-M (ALVR105), and allows potentially hundreds of patients to be treated with virus-specific T-cells manufactured from a single donor, using a proprietary cell selection strategy to match the company’s bank of third-party donor-derived cell lines to patients. AlloVir is advancing multiple mid- and late-stage clinical trials across its product portfolio.

Senior Vice President & Head, Virology Therapeutic Area
2015 - 2021

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

Diana M. Brainard is affiliated with AlloVir, Inc., Gilead Sciences, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Diana M. Brainard. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Diana M. Brainard's profile does not indicate a business or promotional relationship of any kind between RelSci and Diana M. Brainard.